ASTP Masterclass on Clinical Trial Agreements - 21 April 2009, Amsterdam
21 April 2009 - 21 April 2009
Austria
Topics to be covered will include:
• Who should be the parties to the CTA – pharmaceutical company, CRO, university, hospital, technology transfer company, principal investigator, medical staff?
• Work obligations and payment terms; back-to-back arrangements with other service providers
• Early termination and its consequences
• Defining and allocating responsibility, risk and liability, including insurance
• Academic priorities, including publications and intellectual property
• Handling difficult negotiation issues with pharmaceutical companies
• Regulatory issues, including approvals, consents, data protection and medical recordsPlease check the website of ASTP (http://www.astp.net(opens in new window)) for the complete programme and registration.
• Who should be the parties to the CTA – pharmaceutical company, CRO, university, hospital, technology transfer company, principal investigator, medical staff?
• Work obligations and payment terms; back-to-back arrangements with other service providers
• Early termination and its consequences
• Defining and allocating responsibility, risk and liability, including insurance
• Academic priorities, including publications and intellectual property
• Handling difficult negotiation issues with pharmaceutical companies
• Regulatory issues, including approvals, consents, data protection and medical recordsPlease check the website of ASTP (http://www.astp.net(opens in new window)) for the complete programme and registration.